我国新分离虫媒病毒的初步鉴定

1990－1994年,从新疆地区的蚊、蜱和病人血清分离了多株病毒,为了明确这些病毒的分类地位,对其中的20株病毒进行了组织培养细胞感染实验和血清学检验,对部分毒株做了动物接种实验和理化性质鉴定。结果显示：20株病毒均可使BHK－21细胞病变（1－3天）,主要表现为细胞圆宿、聚集,融合,破碎,脱落等;致Vero细胞病变为2－4天;15株病毒致C6／36细胞病变（2－4天）,5株病毒对C6／36细胞连续观察7天未见细胞病变。11株病毒对乳鼠2－4天致死,对成年鼠2－5天致死。选取6株病毒进行理化性质鉴定,4株病毒（90260、91002、91004和91028）对5－氟脱氧尿苷耐受,对乙醚和酸敏感,提示为有膜RNA病毒;一株病毒（90265）对5－氟脱氧尿苷、乙醚和酸均敏感,提示为有膜DNA病毒;另一株病毒（9059）对5－氟脱氧尿苷耐受,对乙醚和酸也耐受,提示可能为无膜RNA肠道病毒。20株病毒中,17株病毒与甲病毒、乙型脑炎病毒和布尼亚病毒的特异性免疫腹水不反应,提示这些病毒中可能不存在甲病毒、黄病毒和布尼亚病毒;3株病毒（90260、91002和91004）只与甲病毒的特异性免疫腹水反应,与乙型脑炎病毒和布尼亚病毒的不反应,提示这三株病毒为甲病毒。     

标记抗体染色病毒空斑计数技术的研究

用细胞病变阳性（ｐｏｓｉｔｉｖｅ ｃｙｔｏｐａｔｈｏｇｅｎｉｃ ｅｆｆｅｃｔ,ＣＰＥ＋ ）病毒马立克氏病毒（Ｍａｒｅｋ＇ｓｄｉｓｅａｓｅ ｖｉｒｕｓ, ＭＤＶ）血清１,２,３ 型以及细胞病变阴性（ｎｅｇａｔｉｖｅ ｃｙｔｏｐａｔｈｏｇｅｎｉｃ ｅｆｆｅｃｔ,ＣＰＥ－ ）病毒猪瘟病毒（Ｈｏｇ ｃｈｏｌｅｒａ ｖｉｒｕｓ,ＨＣＶ）强毒与弱毒和鸡新城疫病毒（Ｎｅｗ ｃａｓｔｌｅ ｄｉｓｅａｓｅｖｉｒｕｓ． ＮＤＶ）Ｌａｓｏｔａ 毒株及其对应的异硫氢酸荧光素（ＦＩＴＣ）标记的特异抗体为试验材料,以免疫荧光抗体技术（ＦＡ）为基础、并加以改进,建立了标记抗体染色病毒空斑计数技术． 该技术不仅能克服常规病毒空斑计数技术不能计数细胞病变阴性病毒和一种样品含有两种或两种以上病毒的各自空斑数的缺点,能迅速准确计数出ＣＰＥ－ 病毒和多病毒样品中病毒各自空斑数及其空斑总数,具较高敏感性、良好的可重复性．     

中国首次分离的Tahyna病毒毒株的生物学特性及分子进化特征分析

2006年夏季,本课题组在新疆喀什地区伽师县库蚊标本中分离到我国首株Tahyna病毒XJ0625株,并发现当地不明原因发热患者存在该病毒感染。本研究通过细胞培养、动物实验、电镜观察、间接免疫荧光及交叉保护中和试验等研究对XJ0625病毒株的细胞易感性、动物致病性、形态学及抗原性等特征进行观察,并应用分子生物学软件对其分子进化特征加以分析。结果发现该毒株可以引起BHK-21细胞病变,乳鼠颅内接种该毒株可以引起死亡。与其他布尼亚病毒形态相似,Tahyna病毒为球形有包膜病毒。该病毒与国际流行Tahyna病毒Bardos92株的抗体作用,在间接免疫荧光试验中呈现阳性荧光信号。空斑减少中和试验结果显示该抗体对XJ0625病毒株的中和效价为1∶3 200。核苷酸序列分析显示,该病毒与Bardos92株处于同一个进化分支,二者S节段同源性为91.8%,M节段同源性为81.9%。     

云南森林脑炎病毒的动物敏感性研究

本文对分离自云南的森林脑炎病毒进行了动物敏感性研究,实验证明云南森林脑炎病毒对小白鼠有较强的致病性,三日龄乳鼠无论经脑内、腹腔、皮下接种均能致病、死亡,但毒力较国内森林脑炎病毒标准株低;三周龄小白鼠经鼻腔接种亦能发病致死。对乳大白鼠、幼年豚鼠和金黄色地鼠能引起发病或死亡,病毒抗原定位主要在脑组织。病理检查表明感染的各种动物脑组织均有明显病变。此外,对鸡胚敏感,能引起BHK_(21)、Vero、Vero-E_6等传代细胞及人胚肾、乳猪肾原代细胞的CPE_0结果表明了云南森林脑炎病毒对细胞、动物的致病性与国内森林脑炎病毒标准株相似,仅毒力稍低。     

流行性乙型脑炎病毒SA14-14-2弱毒株某些体外特征的研究

本文研究了流行性乙型脑炎病毒弱毒14-2株及5-3株的某些体外特征,发现:1.在地鼠肾细胞内弱毒株的病变较强毒株晚;在C6/36细胞内,弱毒株仅出现细胞圆缩、松散、脱落,而强毒株产生类似细胞融合型病变;在LLC-MK2和原代鸡胚细胞内,弱毒株出现模糊不清的针点状小蚀斑,而强毒株则出现清晰的3～5mm大蚀斑。2.在50℃加温条件下,14-2与SA14的热稳定性相同,但5-3的热稳定性明显地较差;两株弱毒株均能在40℃培养条件下繁殖良好,与37℃培养无明显差别,并均能在小鼠巨噬细胞内良好繁殖,但生长速度较强毒株慢,病变也较差。 本文并对弱毒株的免疫原性和ret及T50特征的关系进行了讨论。     

从背点伊蚊体内检出Colti病毒

Colti病毒为呼肠孤病毒科病毒,临床上引起发热、脑炎等症状。为了解东北地区感染情况,于1996年8～9月间采集了东北三省五地蚊虫2327只,计3属5种。对其中620只蚊虫进行了病毒分离,结果从背点伊蚊（Aedesdorsalis）分离出了两株病毒。该病毒能通过0．22μm孔径滤膜,在C6／36细胞上产生病变,对5－Idu和乙醚抵抗,对酸、热敏感。病毒RNA聚丙烯酰胺电泳呈现特有的12个条带。血清学试验阳性,鉴定为Colti病毒。据病毒在传代细胞上的病变表现和对动物的致病性,以及RNA带形分析,认为该病毒可能与北京株差异较大,与云南株区别较小。     

牛泡沫病毒（BSV）3026毒株的分离及分子生物学鉴定

从一头牛免疫缺陷病毒（ＢＩＶ）检测阳性３０２６号牛外周血中,分离到一株病毒,即３０２６病毒株。体外细胞增减和反转录分析证明,此病毒是一反转录病毒。可胎牛肺细胞中引起典型的泡沫样病变,形成合胞体,ＰＣＲ扩增和Ｓｏｕｔｈｅｍ杂交显示,此病毒的ＣＤＮＡ和ＰＣＲ产的均可与牛泡沫病毒（ＢＳＶ）阳性对照的ＨｉｒｔＤＮＡ杂交。３‘ＬＴＲ上游一段３３０ｂｐ的ＰＣＲ产物序理分析表明,３０２６毒株与ＢＳＶ阳性对照相比     

Vero及Vero-dst细胞对犬瘟热病毒敏感性比较

目的为了更好地分离犬瘟热病毒（CDV）并确诊犬瘟热,本实验比较了Vero及Vero-dst细胞对此病毒的敏感性。方法将CDV标准毒株Snyder Hill株及临床犬瘟热阳性犬组织匀浆分别接种Vero及Vero-dst两种细胞,通过观察细胞病变、检测病毒滴度（TCID50）,并通过RT-PCR法进行比较,分析两种细胞对CDV的敏感性。结果接种病毒后Vero细胞盲传5代始终未见细胞病变,而Vero-dst细胞12 h出现了明显的合胞样细胞病变,且RT-PCR扩增出了CDV基因特异性片段。结论 Vero-dst细胞对CDV表现了良好的敏感性,是体外分离培养CDV的一个有效细胞系。而所本实验中使用的Vero细胞并不适于CDV的分离与培养。另外,本实验利用Vero-dst细胞从临床犬瘟热阳性病例中成功分离到了野毒株,并确定其毒力较标准毒株毒力强,可用于进一步的研究。     

10株水痘带状疱疹病毒的分离鉴定与生物学特性

用ＶｅｒｏＥ６细胞从１２例水痘及带状疱疹病人水疱液中分离到１０株病毒,分离阳性率为８３．３％。１０株病毒均具有使感染细胞圆缩、融合、脱落等典型的ＶＺＶ局灶性细胞病变（ＣＰＥ）特点,ＣＰＥ随着传代次数增加而加快。用带状疱疹恢复期病人血清作间接免疫荧光染色镜检,可见典型的感染细胞核内荧光块。１０株病毒感染细胞制成的抗原片,检测５例带状疱疹病人急性期及恢复期血清,荧光抗体滴度均有４倍以上增高。ＶＺＶ对Ｖｅｒｏ细胞敏感;对沙鼠肾,胎兔肾,胎豚鼠肾、肺、脾原代单层细胞不敏感;对乳小白鼠不敏感。毒种在－２０℃保存一周内死亡;但在３０％脱脂牛奶、２０％小牛血清及１０％山梨醇Ｅａｇｌｅ’ｓ液中,液体或真空冷冻干燥－１００℃可保存二年以上。     

森林脑炎病毒对鸡胚单层细胞的致病变作用及其实际应用

从人尸脑组织或蜱分离出的森林脑炎病毒株感染鸡胚皮肤肌单层细胞时,均可出现明显的细胞病变TCID50滴度与小白鼠脑内毒力LD50相一致,可达log 7.0—9.0。病毒如加有被确诊的森林脑炎病人恢复期血清或者免疫动物血清则不出现病变,证明细胞病变作用的特异性。病毒经鸡胚细胞传代后仍保持稳定的致病变作用。应用鸡胚细胞作血清中和试验与小鼠腹腔接种法中和试验测定的抗体结果相一致,而其敏感性和特异性都高于用小鼠法所测结果。本文对森林脑炎病毒在鸡胚细胞引起病变的条件和影响因素及其实际应用价值加以讨论。     

中国首次分离的辛德毕斯病毒XJ-160病毒株感染性全基因组cDNA克隆的构建与分析

报告了中国首次分离的辛德毕斯病毒XJ-160株的感染性全基因组cDNA克隆的构建与鉴定。利用RT—PCR方法获得覆盖病毒全长基因组的cDNA片段,以低拷贝质粒pBR322作为骨架,将基因组cDNA置于SP6RNA聚合酶启动子之后,基因组3’末端带有35个连续的A,通过DNA重组技术组装成病毒基因组全长cDNA克隆。该克隆可在大肠杆菌DH5a中稳定扩增。经体外转录,RNA转录体转染BHK-21细胞,细胞发生病变,恢复病毒滴度达到10^7～10^8PFU／ml。全基因组cDNA克隆构建过程中引入的沉默突变(8453位核苷酸由C变为T)产生XbaⅠ酶切位点作为遗传标记,在子代恢复病毒的基因组中稳定存在。从细胞病变的特征、BHK-21细胞的空斑形态、病毒的抗原性、病毒在细胞中的生长动力学特征以及对乳鼠的致病性等方面比较,恢复病毒和亲本病毒XJ-160没有显著区别,提示获得了具有感染性的XJ-160病毒全长cDNA克隆。该病毒感染性全基因组cDNA克隆可以作为反向遗传学系统,为进一步研究病毒复制和致病机制,以及开发相应的载体表达系统提供分子生物学工具。     

Experimental inoculation of three arboviruses in black-bellied whistling ducks (Dendrocygna autumnalis).

Wild-caught, immature black-bellied whistling ducks (Dendrocygna autumnalis) were inoculated with eastern equine encephalitis (EEE), St. Louis encephalitis (SLE), or western equine encephalitis (WEE) virus. Susceptibility, duration and titer of viremia, and antibody response to these arboviruses were determined. Birds from all inoculated groups became viremic. Higher virus titers occurred in the EEE group but overall mean titers were not significantly different among experimental groups. All birds inoculated with EEE and SLE viruses developed antibodies, and six of seven ducks receiving WEE virus were seropositive. All seropositive ducks had antibodies for at least 59 days, when the study was terminated. The EEE group had significantly more seropositive ducks during more days than the WEE and SLE groups. Geometric mean antibody titers were significantly smaller in the WEE group when compared to the EEE and SLE groups. Control ducks did not develop viremia or antibodies. Gross and histopathologic lesions compatible with viral encephalitis were absent in all of nine ducks necropsied. Black-bellied whistling ducks can develop low and short-term levels of viremia sufficient to infect mosquitoes, but probably cannot contribute significantly to the transmission of EEE and SLE. They may serve as good indicators of virus activity.     

Synthesis,Immunogenicity, and Antigenicity of the Glycoprotein E Fragments of the Tick-Borne Encephalitis Virus

Six peptide fragments of the envelope protein E of the tick-borne encephalitis virus involving the predicted T-helper epitopes were synthesized. Their ability to induce antibodies without conjugation with any high-molecular-mass carrier was studied in mice of three lines. Five of six synthesized peptides exhibited immunogenic properties, which differed in dependence on the haplotype of immunized mice. The peptide binding to the antiviral antibodies was studied, and two peptides were revealed that demonstrated a high ability to recognize the viral antibodies in the horse and human sera. These peptides are promising for the development of diagnostic agents for the tick-borne encephalitis virus.     

Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.

Sera from SIV-infected macaques were found to contain antibodies that reacted with conformation-dependent, group-specific determinants on the SIV envelope protein gp130. These conformation-dependent antibodies exhibited virus neutralizing activity; their presence was associated with protection in vaccine studies. The properties of these antibodies are quite similar to those that have been identified in sera from HIV-infected human subjects. These data suggest that the SIV envelope gp130 remains a candidate for subunit vaccine studies.     

Production of Polyclonal Antibodies to the Recombinant Coat Protein of Citrus tristeza virus and their Effectiveness for Virus Detection

Citrus tristeza virus (CTV) is distributed worldwide and causes the most economically important virus diseases of citrus. Enzyme‐linked immunosorbent assay (ELISA) and/or immunoprinting have become an indispensable tools for large‐scale diagnosis of CTV worldwide. Several CTV detection kits are commercially available, based on either polyclonal or monoclonal antibodies developed against purified virus preparations. We have developed polyclonal antibodies to recombinant p25 CTV coat proteins (rCP) and determined their effectiveness for both trapping and as the intermediate antibody in double‐antibody sandwich indirect (DASI) ELISA. The p25 coat protein gene of three CTV isolates was amplified by RT‐PCR and further cloned and expressed in Escherichia coli cells. The rCP was injected into rabbits and goats for antibody production. Western blotting assays with the rCP CTV‐specific antibodies reacted positively with the homologous and heterologous rCP of the three CTV isolates and with the corresponding native coat protein present in crude sap extracts of CTV‐infected citrus tissue, but not with extracts from healthy tissue. The rCP antibodies from goat and rabbit reacted as both plate trapping and intermediate antibodies in DASI‐ELISA, discriminating healthy and CTV‐infected citrus, with optical density (OD₄₀₅) values in the range of 0.151–2.415 for CTV‐infected samples and less than 0.100 for healthy tissue. Commercially available anti‐CTV antibodies were used as a reference. Previous reports indicate that antibodies developed to recombinant antigens, including those of CTV, may not be functional for trapping the target antigens under non‐denaturing conditions. Our results showed the feasibility of CTV antibodies developed to the rCP for use as both trapping and intermediate antibodies in DASI‐ELISA, when the recombinant antigen was fractioned with polyacrylamide electrophoresis gel and further extensively dialysed against phosphate buffer saline prior to its use as immunogen.     

Possible Evidence for Interference with Venezuelan Equine Encephalitis Virus Vaccination of Equines by Pre-Existing Antibody to Eastern or Western Equine Encephalitis Virus, or Both

During 1971, an epizootic of Venezuelan equine encephalitis (VEE) reached the United States. Laboratory tests were performed on a large number of sick, healthy, unvaccinated, and vaccinated horses. Neutralization (N) tests in cell cultures revealed that 153 of 193 (79.3%) equines outside the state of Texas and 175 of 204 (85.8%) within Texas (82.6% overall) had detectable N antibody to VEE virus a week or more after vaccination. Twenty-six of 40 (65%) non-Texas equines and 18 of 29 (62%) Texas equines which had no detectable antibody against VEE virus a week or more after vaccination had N antibody against Eastern equine encephalitis (EEE) or Western equine encephalitis (WEE) virus or both, whereas only 50 of 153 (32.7%) non-Texas equines and 82 of 175 (46.9%) Texas equines with demonstrable N antibody against VEE also had N antibody against EEE and/or WEE virus. In vaccinated equines, significant negative correlations were found between the occurrence of antibody to VEE and antibody to EEE and/or WEE virus. These findings support the hypothesis that pre-existing antibody to EEE and/or WEE virus may modify or interfere with infection by VEE virus. The epizoologic significance of this possibility is discussed briefly.     

Development,Characterization and Application of Monoclonal Antibodies against Brazilian Dengue Virus Isolates

Dengue is the most prevalent human arboviral disease. The morbidity related to dengue infection supports the need for an early, quick and effective diagnostic test. Brazil is a hotspot for dengue, but no serological diagnostic test has been produced using Brazilian dengue virus isolates. This study aims to improve the development of immunodiagnostic methods for dengue virus (DENV) detection through the production and characterization of 22 monoclonal antibodies (mAbs) against Brazilian isolates of DENV-1, -2 and -3. The mAbs include IgG2bκ, IgG2aκ and IgG1κ isotypes, and most were raised against the envelope or the pre-membrane proteins of DENV. When the antibodies were tested against the four DENV serotypes, different reactivity patterns were identified: group-specific, subcomplex specific (DENV-1, -3 and -4 and DENV-2 and -3) and dengue serotype-specific (DENV-2 or -3). Additionally, some mAbs cross-reacted with yellow fever virus (YFV), West Nile virus (WNV) and Saint Louis encephalitis virus (SLEV). None of the mAbs recognized the alphavirus Venezuelan equine encephalitis virus (VEEV). Furthermore, mAbs D3 424/8G, D1 606/A12/B9 and D1 695/12C/2H were used to develop a capture enzyme-linked immunosorbent assay (ELISA) for anti-dengue IgM detection in sera from patients with acute dengue. To our knowledge, these are the first monoclonal antibodies raised against Brazilian DENV isolates, and they may be of special interest in the development of diagnostic assays, as well as for basic research.     

稳定表达非洲猪瘟病毒P54蛋白的Vero细胞系的建立

旨为建立稳定表达非洲猪瘟病毒(ASFV)P54蛋白的Vero细胞系,将ASFV-P54基因与绿色荧光基因Azami Green的融合基因片段,将其克隆至慢病毒载体pLV-puro中构建重组慢病毒质粒pLV-ASFV-P54-AG,将该质粒与慢病毒包装质粒pH1和pH2共转染HEK-293V细胞,包装表达ASFV-P54蛋白的慢病毒。将重组慢病毒在聚凝胺(Polybrene)的介导下感染Vero细胞,筛选出一株稳定表达ASFV-P54蛋白的Vero细胞系,命名为Vero-AG-ASFV-P54。间接免疫荧光试验表明,该细胞系能够与P54多克隆抗体反应;经波兰国家兽医研究所进一步验证,结果显示,该细胞系与ASFV抗体阳性血清也能发生反应,并且与阴性血清无反应。结果表明,Vero-AG-ASFV-P54细胞系能够稳定高效的表达具有生物活性的ASFV-P54蛋白。     

Eastern equine encephalitis in the United States, 1971: Past and prologue

During 1971, surveillance for equine encephalitis in the United States was increased due to an epizootic of Venezuelan equine encephalomyelitis. Of 1,982 specimens from 1,551 equines, 76 isolates of eastern equine encephalitis (EEE) virus were recovered from 67 individuals. The virus was isolated from 50/176 brains, 8/74 spleens, 14/1,127 sera, and 4/147 whole bloods from infected equines in 12 of the 31 states bounded by or east of the Mississippi River and in Texas and Iowa; no specimens were received from 9 of these 31 states. Thus, EEE virus was isolated from equines in 12 of 22 of these states. Determinations of antibody to EEE and western equine encephalitis (WEE) viruses indicated a relatively high prevalence of infection with EEE virus in the eastern USA and similarly high prevalence of antibody to WEE virus in the western USA. These data indicate that equine infections with EEE virus in the eastern USA are considerably more common than previous surveillance data have suggested. Increased surveillance and submission of specimens to diagnostic laboratories for diagnosis of EEE virus infections in equines are suggested so that a greater proportion of the thousands of unspecified equine encephalitis cases occurring in the United States each year can be laboratory confirmed.